BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21057033)

  • 21. Efficacy of monotherapies and artesunate-based combination therapies in children with uncomplicated malaria in Somalia.
    Warsame M; Atta H; Klena JD; Waqar BA; Elmi HH; Jibril AM; Hassan HM; Hassan AM
    Acta Trop; 2009 Feb; 109(2):146-51. PubMed ID: 19026606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of artemisinin-based combination therapy for treatment of persons with uncomplicated Plasmodium falciparum malaria in West Sumba District, East Nusa Tenggara Province, Indonesia, and genotypic profiles of the parasite.
    Asih PB; Dewi RM; Tuti S; Sadikin M; Sumarto W; Sinaga B; van der Ven AJ; Sauerwein RW; Syafruddin D
    Am J Trop Med Hyg; 2009 Jun; 80(6):914-8. PubMed ID: 19478248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of artemisinin-based combination therapies.
    German PI; Aweeka FT
    Clin Pharmacokinet; 2008; 47(2):91-102. PubMed ID: 18193915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malaria: an update for physicians.
    Nadjm B; Behrens RH
    Infect Dis Clin North Am; 2012 Jun; 26(2):243-59. PubMed ID: 22632637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence.
    Rehman K; Lötsch F; Kremsner PG; Ramharter M
    Int J Infect Dis; 2014 Dec; 29():268-73. PubMed ID: 25448338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The treatment of malaria].
    Visser BJ; Bierhoff M; van Gool T; van Hattem JM; Grobusch MP; van Vugt M
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31166095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimalarial compounds: from bench to bedside.
    Olliaro PL; Taylor WR
    J Exp Biol; 2003 Nov; 206(Pt 21):3753-9. PubMed ID: 14506210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacovigilance of antimalarial treatment in Africa: is it possible?
    Talisuna AO; Staedke SG; D'Alessandro U
    Malar J; 2006 Jun; 5():50. PubMed ID: 16780575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe malaria not responsive to artemisinin derivatives in man returning from Angola to Vietnam.
    Van Hong N; Amambua-Ngwa A; Tuan NQ; Cuong do D; Giang NT; Van Dung N; Tinh TT; Van Tien N; Phuc BQ; Duong TT; Rosanas-Urgell A; D'Alessandro U; Van Geertruyden JP; Erhart A
    Emerg Infect Dis; 2014 Jul; 20(7):1199-202. PubMed ID: 24963881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe malaria: artesunate is now the standard treatment.
    Prescrire Int; 2011 Oct; 20(120):245. PubMed ID: 21970093
    [No Abstract]   [Full Text] [Related]  

  • 32. The Treatment of Plasmodium knowlesi Malaria.
    Barber BE; Grigg MJ; William T; Yeo TW; Anstey NM
    Trends Parasitol; 2017 Mar; 33(3):242-253. PubMed ID: 27707609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress in malaria and artemisinin combination therapy: Pros and Cons.
    Kavishe RA; Koenderink JB; Alifrangis M
    FEBS J; 2017 Aug; 284(16):2579-2591. PubMed ID: 28467668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed haemolysis after artesunate treatment of severe malaria - review of the literature and perspective.
    Rolling T; Agbenyega T; Krishna S; Kremsner PG; Cramer JP
    Travel Med Infect Dis; 2015; 13(2):143-9. PubMed ID: 25812775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artemisinin-based combination therapy for knowlesi malaria.
    Ramharter M
    Lancet Infect Dis; 2016 Feb; 16(2):134-6. PubMed ID: 26603170
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in global biotechnology and local resources to treat malaria.
    Campagna AM; Patnaik MM
    Minn Med; 2009 Feb; 92(2):44-5. PubMed ID: 19331290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artesunate-tafenoquine combination therapy promotes clearance and abrogates transmission of the avian malaria parasite Plasmodium gallinaceum.
    Tasai S; Saiwichai T; Kaewthamasorn M; Tiawsirisup S; Buddhirakkul P; Chaichalotornkul S; Pattaradilokrat S
    Vet Parasitol; 2017 Jan; 233():97-106. PubMed ID: 28043395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria and artemisinin derivatives: an updated review.
    Ansari MT; Saify ZS; Sultana N; Ahmad I; Saeed-Ul-Hassan S; Tariq I; Khanum M
    Mini Rev Med Chem; 2013 Nov; 13(13):1879-902. PubMed ID: 24070206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The birth of artemisinin.
    Ma N; Zhang Z; Liao F; Jiang T; Tu Y
    Pharmacol Ther; 2020 Dec; 216():107658. PubMed ID: 32777330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of artemisinin resistance in malaria therapy.
    Naß J; Efferth T
    Pharmacol Res; 2019 Aug; 146():104275. PubMed ID: 31100335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.